Related by context. All words. (Click for frequent words.) 69 JANUVIA 68 lubiprostone 65 PRISTIQ 64 TORISEL 64 ACTEMRA TM 63 PREZISTA 63 APRISO 63 ONGLYZA 62 CANCIDAS 62 SPRYCEL 62 albinterferon alfa 2b 62 oral rivaroxaban 62 SILENOR TM 62 KAPIDEX 62 CONCERTA 62 ARCOXIA 62 diabetic neuropathic pain 62 APTIVUS r 62 LIALDA 62 teduglutide 62 forodesine 62 JANUMET 62 PEG INTRON 62 NUVIGIL 61 TYGACIL 61 Chronic Idiopathic Constipation 61 BROVANA 61 Lubiprostone 61 DEXILANT 61 CIMZIA TM 61 CIMZIA ™ 61 VPRIV 61 TYZEKA 61 PROMACTA 61 Ixempra 61 ARIXTRA 61 Victoza R 61 Vivaglobin 61 Bezielle 61 ARICEPT 61 APTIVUS 61 prucalopride 61 Cimzia R 61 INVEGA 60 gemifloxacin 60 ARCALYST 60 eltrombopag 60 ACTEMRA 60 DDP# 60 VIMOVO 60 VIRAMUNE XR 60 alvimopan 60 EFFEXOR XR 60 ZOLINZA 60 REMICADE ® 60 Keppra R 60 NUEDEXTA 60 SAPHRIS 60 Increlex ® 60 INVEGA ® 60 lacosamide 60 chronic idiopathic constipation 60 TYKERB 60 FIRMAGON 60 rilonacept 60 PREZISTA r 60 ZOSTAVAX 60 ISTODAX 60 ZYVOX 60 EXJADE 60 ORENCIA ® 60 ORENCIA 60 ISENTRESS 60 octreotide LAR 60 Azilect ® 60 ABILIFY 59 Vimpat ® 59 tapentadol ER 59 FASLODEX 59 FIRAZYR 59 ARCALYST ® 59 AZILECT 59 IBS C 59 HuMax CD4 59 BARACLUDE 59 postoperative ileus 59 Cimzia TM 59 tegaserod 59 methylnaltrexone 59 Keppra ® 59 mg dose 59 Locteron 59 dyskinesia PD LID 59 post herpetic neuralgia PHN 59 LYSTEDA 59 AGILECT ® 59 diarrhea predominant irritable 59 INVEGA SUSTENNA 59 paliperidone palmitate 59 AZILECT ® 59 Emselex 59 maximally tolerated dose 59 Golimumab 59 pitavastatin 59 IRESSA 59 Traficet EN 59 palonosetron 59 sorafenib tablets 59 salmeterol fluticasone 59 LibiGel ® 59 elagolix 59 NOXAFIL 59 Adalimumab 59 pseudobulbar affect PBA 58 TEMODAL 58 GAMMAGARD LIQUID 58 eszopiclone 58 CAELYX 58 Cellegesic 58 Victoza ® 58 VYTORIN 58 TRILIPIX 58 RISPERDAL ® 58 Zavesca R 58 mcg dose 58 canakinumab 58 AZILECT R 58 ramelteon 58 SINGULAIR 58 Ophena TM 58 LATUDA 58 AVELOX 58 GARDASIL 58 divalproex sodium 58 TELCYTA 58 HUMIRA 58 VELCADE 58 ORENCIA R 58 Cimzia ® 58 MoxDuo IR 58 SCIg 58 SEROQUEL 58 Tekturna HCT 58 CYCLOSET 58 FROVA 58 aripiprazole 58 Vandetanib 58 AGGRASTAT R 58 Plenaxis TM 58 #mg/day [001] 58 dose cohort 58 tipranavir r 58 pramlintide 58 IXEMPRA 58 Perforomist ™ Inhalation Solution 58 SEBIVO 58 Pentacel vaccine 58 lopinavir ritonavir 58 YERVOY 58 Vicinium TM 58 oral anticoagulant 58 FOLOTYN 58 Anturol 58 AZOR 58 BENICAR HCT 58 REYATAZ 58 posaconazole 58 INTELENCE 58 RAPTIVA 58 ACIPHEX 58 Raptiva ® 58 Tolvaptan 58 oral antidiabetic medication 58 GAMMAGARD 58 COMFORT II 58 AMEVIVE 58 Aptivus 58 Methylnaltrexone 58 mg BID 58 Tamibarotene 58 MAGE A3 ASCI 58 Sandostatin LAR 58 INTEGRILIN 58 YONDELIS 58 ENBREL 58 LT NS# 57 overactive bladder syndrome 57 glatiramer acetate 57 Zavesca ® 57 ZOMIG Nasal Spray 57 Dual Opioid 57 ZADAXIN 57 Plicera 57 HuMax EGFr 57 RSD# 57 Levetiracetam 57 torezolid phosphate 57 thymalfasin 57 Phenoptin 57 Fibrillex TM 57 brivaracetam 57 interferon alfa 2b 57 RoACTEMRA 57 elotuzumab 57 REMINYL ® 57 AMPYRA 57 STELARA 57 talactoferrin 57 diabetic gastroparesis 57 CTAP# Capsules 57 LEUKINE 57 acyclovir Lauriad R 57 Dextofisopam 57 trospium 57 LEXIVA 57 vandetanib 57 rFIXFc 57 Laquinimod 57 PRADAXA 57 Zoraxel 57 tocilizumab 57 KETEK 57 cannabinor 57 mesalamine 57 desvenlafaxine succinate 57 Perforomist TM Inhalation Solution 57 Onbrez Breezhaler 57 LEVADEX 57 Amigal 57 refractory gout 57 C1 INH 57 selective modulator 57 ONTAK 57 Duloxetine 57 Icatibant 57 RhuDex ® 57 visilizumab 57 R#/MEM # 57 subcutaneous formulation 57 edoxaban 57 Besivance 57 EOquin TM 57 certolizumab pegol 57 teriflunomide 57 OMNARIS HFA 57 vasomotor symptoms 57 ABILIFY R 57 Inhalation Solution 57 Zerenex 57 ULORIC 57 ABILIFY ® 57 ERBITUX 57 nebulized formoterol fumarate 57 acute HAE attacks 57 TREDAPTIVE 57 rifaximin 57 micafungin 57 insulin detemir 57 FAMPYRA 57 tolerability profiles 57 RAPAFLO 57 Clolar 57 AGILECT R 57 LIVALO 57 tanespimycin 57 AVANDIA 57 LY# [003] 57 NEUPOGEN 57 Ventavis 57 KRN# 57 Aptivus ® 57 Dasatinib 57 Frova ® 57 Proquin XR 57 Chemophase 56 Dalbavancin 56 Engerix B 56 BAY #-# 56 pharmacokinetic profiles 56 FOSRENOL 56 efalizumab 56 Hizentra 56 sitagliptin 56 Mylotarg 56 INCB# [002] 56 EOquin 56 Hycamtin 56 administered orally 56 myopathy rhabdomyolysis 56 COPEGUS 56 INVEGA R 56 pegfilgrastim 56 BEXXAR 56 Genasense ® 56 Certican 56 OPAXIO 56 certolizumab 56 Vaprisol 56 Welchol 56 PROLASTIN C 56 Linaclotide 56 Tracleer R 56 SCH # 56 NASONEX 56 interferon beta 1b 56 Tasimelteon 56 Elitek 56 CINV 56 active comparator 56 antithrombotics 56 OncoVEX GM CSF 56 PEGINTRON TM 56 Multaq R 56 PRT# 56 SEROQUEL XR 56 #mg dose [003] 56 Ophena 56 dabigatran etexilate 56 placebo controlled Phase 56 mg QD 56 Tasigna 56 Mycamine 56 6R BH4 56 ARIMIDEX 56 clobazam 56 menopausal symptom 56 opioid induced constipation 56 Eloxatin R 56 BYDUREON 56 oral iron chelator 56 Increlex R 56 Tekamlo 56 Copegus ribavirin 56 ezogabine 56 administered subcutaneously 56 tacrolimus ointment 56 NeuroStar TMS Therapy 56 #mg doses [002] 56 generalized anxiety disorder GAD 56 Gabapentin GR 56 telbivudine 56 pharmacokinetic PK profile 56 Lactobacillus KW 56 oral prodrug 56 INTUNIV 56 decitabine 56 NOXAFIL Oral Suspension 56 Rifaximin 56 SUTENT 56 ARIKACE 56 rindopepimut 56 MoxDuo TM IR 56 REVLIMID ® 56 proton pump inhibitor PPI 56 Silodosin 56 RSD# oral 56 reslizumab 56 ZETIA 56 Clevudine 56 dextofisopam 56 SYMBICORT 56 DOXIL 56 paliperidone ER 56 LY# [002] 56 RG# [001] 56 Xyrem ® 56 investigational compound 56 dosing frequency 56 tolerability 56 Phase 2a trial 56 PROVIGIL 56 VFEND 56 docetaxel Taxotere ® 56 Torisel 56 alvespimycin 56 Taxotere R 56 HQK 56 metformin HCl 56 Naglazyme 56 oral FTY# 56 overactive bladder OAB 56 Tarceva TM 56 EFAPROXYN 56 Filgrastim 55 lomitapide 55 oral ridaforolimus 55 Tygacil 55 Pirfenidone 55 Neulasta ® 55 PEG Interferon lambda 55 XGEVA 55 ibandronate 55 proton pump inhibitor 55 XIFAXAN 55 HCV SPRINT 55 HZT 55 LUNESTA 55 FOSRENOL R 55 Boceprevir 55 aripiprazole Abilify 55 Amrubicin 55 Adlea 55 dosing cohort 55 VAPRISOL 55 NEXIUM 55 non metastatic osteosarcoma 55 TREANDA 55 BARACLUDE R 55 DexaSite 55 peginterferon alfa 55 BENICAR 55 diabetic peripheral neuropathic pain 55 CAPHOSOL 55 TMC# [002] 55 Irinotecan 55 ADX# 55 ORMD 55 octreotide 55 tezampanel 55 InterStim Therapy 55 antiepileptic drug 55 BYETTA 55 ropinirole 55 Betaferon ® 55 beclomethasone dipropionate 55 Dapagliflozin 55 Q#IR 55 blinatumomab 55 sorafenib Nexavar 55 Hypoactive Sexual Desire Disorder 55 INTEGRILIN R eptifibatide Injection 55 VICTRELIS 55 oxcarbazepine 55 coadministration 55 abatacept 55 carcinoid syndrome 55 Betaferon R 55 DAVANAT 55 oral renin inhibitor 55 linaclotide 55 DASISION 55 riociguat 55 alfa 2a 55 oxymorphone ER 55 Tavocept 55 Bronchitol 55 Aclidinium 55 opioid induced bowel dysfunction 55 MAXALT 55 mipomersen 55 Actemra tocilizumab 55 Triolex 55 SPRYCEL ® 55 inhaled iloprost 55 Ozarelix 55 interferon gamma 1b 55 CCX# 55 Serdaxin 55 μg dose 55 lixisenatide 55 solifenacin 55 #mg dose [001] 55 MYCAMINE 55 mertansine 55 CIMZIA TM certolizumab pegol 55 superficial bladder cancer 55 valopicitabine 55 cutaneous T cell 55 adult chronic ITP 55 velafermin 55 fenofibric acid 55 hyperphenylalaninemia HPA due 55 GATTEX 55 THALOMID 55 ruxolitinib 55 Synvisc One 55 DPNP 55 ziconotide 55 febuxostat 55 constipation OIC 55 VIIBRYD 55 mesalazine 55 UPLYSO 55 oxycodone CR 55 cinacalcet 55 antiemetics 55 xanthine oxidase inhibitor 55 relapsed SCLC 55 chronic angina 55 functional dyspepsia 55 mGluR5 NAM 55 SELZENTRY 55 REBETOL 55 Dacogen injection 55 PRTX 55 CUBICIN 55 Azedra 55 panitumumab Vectibix 55 KOMBIGLYZE XR 55 Firazyr 55 REYATAZ R 55 cIAI 55 STELARA ™ 55 GEMZAR 54 investigational drug 54 GnRH agonists 54 eosinophilic asthma 54 romiplostim 54 Nexavar ® 54 oral diclofenac 54 JAK inhibitor 54 non constipation irritable 54 Noxafil 54 chlorambucil 54 Oral NKTR 54 post herpetic neuralgia 54 NGX# 54 ZACTIMA 54 efficacy tolerability 54 SIMPONI 54 renal toxicity 54 ocular allergies 54 Lialda 54 Mipomersen 54 Rezular 54 corticosteroid therapy 54 dosage regimens 54 leukotriene receptor antagonists 54 AVODART 54 rufinamide 54 Ketotransdel TM 54 PRIALT 54 hereditary antithrombin deficiency 54 ATACAND 54 rilpivirine 54 tolerability profile 54 HspE7 54 RLY# 54 DORIBAX 54 Evoltra 54 placebo controlled clinical 54 regadenoson 54 mucositis 54 Phase IIb clinical 54 budesonide foam 54 BoNTA 54 systemic absorption 54 LEXIVA r 54 bicifadine 54 Omalizumab 54 Taxotere ® 54 Natalizumab 54 Arixtra 54 MEVACOR 54 oral deforolimus 54 plus dexamethasone 54 pain palliation 54 Ixiaro 54 AEGR 54 MYOBLOC 54 H2 blocker 54 tapentadol IR 54 motesanib 54 NPH insulin 54 HGS ETR1 54 deferiprone 54 Lantus ® 54 ruboxistaurin 54 vicriviroc 54 REMICADE 54 atherothrombotic events 54 CoFactor 54 tipranavir 54 NATRECOR R 54 Pegasys peginterferon alfa 2a 54 monotherapy 54 Afinitor 54 Rebif ® 54 acute bronchospasm 54 hyperuricemia 54 Lantus R 54 ulimorelin 54 tolvaptan 54 oral formulation 54 azacitidine 54 nucleoside analog 54 Sandostatin LAR Depot 54 Eculizumab 54 bosentan 54 TELINTRA 54 liposomal amphotericin B 54 nitazoxanide 54 Phase 2b study 54 ascending dose 54 Pramipexole 54 primary hypercholesterolemia 54 rotigotine 54 LEVAQUIN 54 biologic therapy 54 NVA# 54 Phase IIb trials 54 COPAXONE R 54 Omacetaxine mepesuccinate 54 systemically administered 54 delayed CINV 54 treprostinil 54 adalimumab 54 TNF alpha inhibitor 54 zileuton 54 omega interferon 54 VELCADE melphalan 54 antiarrhythmic drug 54 levetiracetam 54 RELISTOR 54 cystinosis patients 54 pharmacokinetic studies 54 INTEGRILIN ® 54 AGGRASTAT ® 54 platelet inhibitor 54 Eltrombopag 54 SNRI 54 TNF inhibitor 54 lapatinib Tykerb 54 Hydroxyurea 54 CIMZIA 54 exenatide 54 hypoparathyroidism 54 ambrisentan 54 CIPN 54 docetaxel chemotherapy 54 Navelbine ® 54 Raptiva R 54 PEG PAL 54 AEG# 54 NIASPAN 54 Leukine 54 DETROL LA 54 pharmacodynamic properties 54 Allovectin 7 ® 54 AeroLEF TM 54 tgAAC# 54 phase IIb 54 Durezol 54 pegylated interferon alfa 2a 54 OAB symptoms 54 BenzaClin R 53 DU #b 53 REVLIMID R 53 Alinia 53 AVONEX 53 cilengitide 53 clevidipine 53 formerly LymphoStat B 53 zolmitriptan 53 mycophenolate mofetil 53 abiraterone acetate 53 INC# 53 Cariprazine 53 IBS symptoms 53 GERD symptoms 53 Alzhemed TM 53 phase IIa clinical 53 TNF antagonist 53 vidofludimus 53 ELND# 53 celgosivir 53 ACZ# 53 REYATAZ ® 53 Sycrest 53 desloratadine 53 ADAGIO study 53 Targretin capsules 53 Panzem R 53 Phase 1b trial 53 Diovan HCT 53 terlipressin 53 Rivaroxaban 53 tasocitinib 53 Aloxi 53 glufosfamide 53 Zomig 53 calcineurin inhibitors 53 interferon alfa 53 amrubicin 53 eprotirome 53 Moxifloxacin 53 Zebinix R 53 Aryplase 53 golimumab 53 recurrent herpes labialis 53 Phase 2a clinical 53 zonisamide SR 53 Archexin 53 hepatitis C HCV 53 subcutaneously administered 53 EVIZON 53 candidemia 53 FTY# fingolimod 53 ProSavin 53 rHuPH# 53 hyperplasia BPH 53 AVASTIN 53 tiotropium bromide 53 Everolimus 53 post operative ileus 53 DAPT 53 Peg IFN 53 ELACYT 53 Peginterferon 53 tolterodine 53 subcutaneous injections 53 VA# [002] 53 Gamunex 53 liposome injection 53 fluticasone furoate 53 noninfectious uveitis 53 Gemzar ® 53 Zolinza 53 migraine prophylaxis 53 infliximab Remicade 53 eculizumab 53 CorVue ™ 53 AzaSite Plus 53 gout flares 53 esomeprazole Nexium 53 Androxal TM 53 STELARA TM 53 hypercalcemia 53 relapsing MS 53 heterozygous FH 53 Virulizin ® 53 Pemetrexed 53 Phase 2b trial 53 PF # [001] 53 clodronate 53 VaD 53 apneic episodes 53 vismodegib 53 systemic corticosteroid 53 Perforomist Inhalation Solution 53 Altastaph 53 laquinimod 53 dosage regimen 53 chronic ITP 53 desmopressin 53 pivotal Phase III 53 lanthanum carbonate 53 Phase IIIb clinical 53 romidepsin 53 pregabalin Lyrica 53 PEGylated interferon beta 1a 53 Xyzal ® 53 orally administered 53 non selective NSAIDs 53 EPZICOM 53 Cimzia ® certolizumab pegol 53 clinical trials Multikine 53 Diabetic Macular Edema 53 spontaneous bowel movements 53 confirmatory Phase III 53 Hepatotoxicity 53 LymphoStat B 53 analgesic efficacy 53 Clolar ® 53 aliskiren 53 Etanercept 53 amphotericin B 53 placebo controlled studies 53 blinded randomized placebo controlled 53 HGS ETR2 53 RE SURGE 53 Sym# 53 tenofovir emtricitabine 53 subcutaneous SC 53 pegloticase 53 RECOTHROM 53 IGIV 53 adalimumab Humira 53 pegylated interferon alfa 53 Detrol LA 53 PEGASYS ® 53 PegIntron 53 relapsed MM 53 Hyphanox 53 active ankylosing spondylitis 53 postherpetic neuralgia 53 FUSILEV 53 relapsing remitting MS RRMS 53 ustekinumab 53 acarbose 53 desvenlafaxine 53 relapsed multiple myeloma 53 Rebetol 53 SNT MC# 53 Triptan 53 REVLIMID lenalidomide 53 Topiramate 53 factor Xa inhibitor 53 PEGINTRON 53 tamibarotene 53 inecalcitol 53 Parnate 53 candesartan cilexetil 53 pramipexole 53 mg kg dose 53 SPIRIVA HandiHaler 53 Octreolin 53 miconazole Lauriad ® 53 Aclasta 53 Exforge 53 partial onset seizures 53 FACTIVE 53 dexpramipexole 53 phase Ib 53 COREG 53 anticonvulsant medications 53 FOLOTYN ® 53 tasimelteon 53 huC# DM4 52 fidaxomicin 52 FOSRENOL ® 52 docetaxel Taxotere R 52 alfuzosin 52 letrozole Femara 52 pharmacokinetic PK study 52 surrogate endpoint 52 chronic idiopathic thrombocytopenic purpura 52 NP2 Enkephalin 52 intravenous bisphosphonates 52 sertraline Zoloft 52 pharmacokinetic profile 52 8mg/kg 52 Phase IIa trial 52 alicaforsen enema 52 chemotherapy induced neutropenia 52 Fludara 52 leukotriene receptor antagonist 52 idraparinux 52 BRIM2 52 invasive candidiasis 52 pomalidomide 52 MBP# [001] 52 briakinumab 52 PS# [001] 52 insulin lispro 52 relapsing multiple sclerosis 52 VIDAZA 52 placebo controlled clinical trials 52 omacetaxine 52 HuMax CD# 52 AVE# 52 AVINZA 52 receptor tyrosine kinase inhibitor 52 Actemra 52 topical NSAIDs 52 brand ciclesonide HFA 52 BeneFIX 52 dose escalation trial 52 cholinesterase inhibitor 52 ancrod 52 vildagliptin 52 mg doses 52 quinolone 52 orally bioavailable 52 severe exacerbations 52 FSAD 52 TRISENOX 52 ciclesonide 52 FOLFOX4 52 INCB# [001] 52 pharmacokinetic characteristics 52 lisdexamfetamine dimesylate 52 sunitinib malate 52 bifeprunox 52 evaluating tivozanib 52 Phase 1a clinical 52 Pegasys ® 52 ganetespib 52 panitumumab 52 Exenatide 52 ACTOS 52 XIAFLEX 52 Evoltra ® 52 Interferon alpha 52 IPX# 52 PRECiSE 52 USL# 52 weekly subcutaneous injections 52 intranasal corticosteroid 52 depsipeptide 52 Phase 2b 52 rALLy trial 52 pouchitis 52 Hepatocellular Carcinoma HCC 52 Phase 2b clinical 52 Elocalcitol 52 Phase #b/#a trial 52 angiotensin receptor blocker ARB 52 Ilaris 52 mcg kg 52 antiretroviral agents 52 direct renin inhibitor 52 peg IFN 52 sipuleucel T 52 hour bronchodilation 52 Mesalamine 52 cardiac toxicity 52 Phase Ia 52 Tyrima 52 orthostatic hypotension 52 Afatinib 52 Bronchial Thermoplasty 52 MoxDuo 52 rFVIIa 52 thromboembolic events 52 Phase 2a 52 MIRCERA 52 placebo controlled trials 52 TLK# 52 interferon beta 52 HGS# 52 heavy menstrual bleeding 52 acute postoperative 52 mapatumumab 52 Toxicities 52 Mirapexin 52 dose escalation 52 ofatumumab 52 ularitide 52 mg/m2 dose 52 diarrhea flatulence 52 events AEs 52 Rebif R 52 TNF antagonists 52 DEFLUX 52 ascending doses 52 chronic constipation 52 Stanate R 52 Vimpat lacosamide 52 inhibitor RG# 52 Kepivance 52 lupus nephritis 52 sedating antihistamine 52 enzastaurin 52 bowel syndrome Non 52 erlotinib Tarceva ® 52 ALIMTA 52 satraplatin 52 LHRH agonists 52 vaginal atrophy 52 limiting toxicity 52 lymphoma CTCL 52 fenofibrate 52 plus gemcitabine 52 elacytarabine 52 eniluracil 52 vinorelbine 52 MAP# 52 ISIS # 52 anakinra 52 metastatic neuroendocrine tumors 52 ToGA 52 GERD 52 alpha 2a 52 IFN beta 52 Velcade bortezomib 52 darunavir 52 acid regurgitation 51 pharmacokinetic PK 51 levofloxacin 51 oral antiviral 51 Telmisartan 51 bronchodilation 51 trabectedin 51 peginterferon alfa 2a 51 bosutinib 51 CLARITY study 51 Cladribine Tablets 51 atacicept 51 nab paclitaxel 51 ADVEXIN 51 topical formulation 51 HCV RESPOND 2 51 Telavancin 51 invasive aspergillosis 51 galiximab 51 chronic anal fissures 51 mg TID 51 topical calcineurin inhibitors 51 #mg BID [001] 51 DULERA 51 Ceplene/IL-2 51 ONGLYZA ™ 51 pramlintide metreleptin combination 51 ThermoDox ® 51 natalizumab 51 telcagepant 51 ADVANCE PD 51 favorable pharmacokinetic profile